Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update
TR Porter, SL Mulvagh, SS Abdelmoneim… - Journal of the American …, 2018 - Elsevier
The use of ultrasound enhancing agents (UEAs) has become an integral component of
echocardiography practice. Since the 2008 American Society of Echocardiography (ASE) …
echocardiography practice. Since the 2008 American Society of Echocardiography (ASE) …
Coronary microvascular obstruction: the new frontier in cardioprotection
G Heusch - Basic Research in Cardiology, 2019 - Springer
Cardioprotection aims at infarct size reduction and improvement of clinical outcome from
myocardial infarction. The translation of cardioprotection from preclinical and promising …
myocardial infarction. The translation of cardioprotection from preclinical and promising …
Coronary microvascular obstruction in acute myocardial infarction
G Niccoli, G Scalone, A Lerman… - European heart …, 2016 - academic.oup.com
The success of a primary percutaneous intervention (PCI) in the setting of ST elevation
myocardial infarction depends on the functional and structural integrity of coronary …
myocardial infarction depends on the functional and structural integrity of coronary …
Coronary microvascular dysfunction: mechanisms and functional assessment
Obstructive disease of the epicardial coronary arteries was recognized as the cause of
angina pectoris> 2 centuries ago, and sudden thrombotic occlusion of an epicardial …
angina pectoris> 2 centuries ago, and sudden thrombotic occlusion of an epicardial …
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection
The coronary circulation is both culprit and victim of acute myocardial infarction. The rupture
of an epicardial atherosclerotic plaque with superimposed thrombosis causes coronary …
of an epicardial atherosclerotic plaque with superimposed thrombosis causes coronary …
Myocardial no-reflow in humans
In a variable proportion of patients presenting with ST-segment elevation myocardial
infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …
infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …
Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017
Contrast echocardiography is widely used in cardiology. It is applied to improve image
quality, reader confidence and reproducibility both for assessing left ventricular (LV) …
quality, reader confidence and reproducibility both for assessing left ventricular (LV) …
No-reflow phenomenon in the heart and brain
The no-reflow phenomenon refers to the observation that when an organ is made ischemic
by occlusion of a large artery supplying it, restoration of patency in that artery does not …
by occlusion of a large artery supplying it, restoration of patency in that artery does not …
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
G Ndrepepa, K Tiroch, M Fusaro, D Keta… - Journal of the American …, 2010 - jacc.org
Objectives: The objective of this study was to investigate the impact of no-reflow
phenomenon on 5-year mortality among patients with acute ST-segment elevation …
phenomenon on 5-year mortality among patients with acute ST-segment elevation …
[HTML][HTML] “No-reflow” phenomenon: A contemporary review
Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …
patients with STEMI according to current international guidelines of the European Society of …